The FCPA paparazzi like to wring its hands over anti-corruption compliance in China. Some of the wringing makes sense; some does not. No company should avoid entering or expanding into China because of corruption risks. Any company which decides not to enter China for that reason has a limited perspective. China is a corruption compliance challenge. You must enter China with a full plate of...
Companies frequently ignore the reality of FCPA enforcement and risks. In the quest to ensure compliance, companies sometimes focus too much on the minutiae of compliance policies. It is a mistake to devote the time and resources to answering these types of questions instead of focusing on some of the more significant issues facing compliance officers and in-house counsel. The best illustration of this point...
Press reports have come out with supposed “news” – the Justice Department is considering launching a new industry sweep of global retailers. This is no surprise. Recent events have underscored the risks that global retailers face when entering new markets. There are plenty of risks facing global retailers – their business depends on customs approvals, licensing and zoning permits. The Justice Department’s launch of a...
The stakes are high when it comes to a False Claims Act lawsuit. Given the trebling of damages and a potential $11,000 per claim, a company can quickly face exposure to millions of dollars in liability. A potential False Claim Act lawsuit is filed under seal. How can you learn about a potential false claim filing? Since most false claims act cases are filed by...
The Justice Department takes a lot of flack from the business community for settling civil and criminal cases with large fines and penalties. The recent GlaxoSmithKline settlement of $3 billion underscored an important question – are fines a cost of doing business? Or do high fines deter corporate misconduct? The answer to this question is hard to determine. Economists argue that behavior is the result...
The Chamber of Commerce, the FCPA Professor and others have argued for a corporate compliance defense to an FCPA charge. Their argument is that a defense will increase corporate incentives to implement effective compliance programs. One alternative which is not discussed very often is to increase the benefit for an effective corporate compliance program under the US Sentencing Guidelines. Right now, companies can get a...
Doctors and health care service providers are under the False Claims Act microscope. The risks are significant and the costs can be astronomical. For all the obvious risks, doctors, hospitals, PPOs, HMOs, and health care providers need to pay more attention. They are targets and the government knows it has an army of potential whistleblowers and lawyers ready to jump on them to seek monetary...
If you want to see how the SEC’s whistleblower program may look in a few years, all you need to do is take a look at the False Claims Act and the role that whistleblowers play in the enforcement of the Act. Whistleblowers are the most important tool in the government’s FCA enforcement arsenal. They are authorized by qui tam provisions (meaning “he who prosecutes...
If you do business with the government (e.g. defense industry or health care), your greatest risk is the False Claims Act. The United States government is the world’s largest purchaser of goods and services. The government spends money in all sectors of industries and services. In addition to purchasing goods and services, the government, through various entitlement and guarantor programs, reimburses industries for providing services...
One of the more frequent questions I hear during webinars and at seminars centers on the issue of facilitation payments. Often the question is “Do you really believe that companies can comply with a flat-out ban on facilitation payments?” The UK Bribery Act, which continues its dormant existence, prohibits all facilitation payments. This is in keeping with all the do-gooders who urge an international prohibition...
